首页> 美国卫生研究院文献>Microorganisms >Inhibition of Type III Interferon Expression in Intestinal Epithelial Cells—A Strategy Used by Coxsackie B Virus to Evade the Host’s Innate Immune Response at the Primary Site of Infection?
【2h】

Inhibition of Type III Interferon Expression in Intestinal Epithelial Cells—A Strategy Used by Coxsackie B Virus to Evade the Host’s Innate Immune Response at the Primary Site of Infection?

机译:抑制III型干扰素在肠上皮细胞中的表达 - 柯萨基B病毒用于避免宿主在感染初始部位的宿主的策略?

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Increasing evidence highlights the importance of the antiviral activities of the type III interferons (IFNλs; IL-28A, IL-28B, IL29, and IFNλ4) in the intestine. However, many viruses have developed strategies to counteract these defense mechanisms by preventing the production of IFNs. Here we use infection models, a clinical virus isolate, and several molecular biology techniques to demonstrate that both type I and III IFNs induce an antiviral state and attenuate Coxsackievirus group B (CVB) replication in human intestinal epithelial cells (IECs). While treatment of IECs with a viral mimic (poly (I:C)) induced a robust expression of both type I and III IFNs, no such up-regulation was observed after CVB infection. The blunted IFN response was paralleled by a reduction in the abundance of proteins involved in the induction of interferon gene transcription, including TIR-domain-containing adapter-inducing interferon-β (TRIF), mitochondrial antiviral-signaling protein (MAVS), and the global protein translation initiator eukaryotic translation initiation factor 4G (eIF4G). Taken together, this study highlights a potent anti-Coxsackieviral effect of both type I and III IFNs in cells located at the primary site of infection. Furthermore, we show for the first time that the production of type I and III IFNs in IECs is blocked by CVBs. These findings suggest that CVBs evade the host immune response in order to successfully infect the intestine.
机译:越来越多的证据突出了III型干扰素(IFNλsss;IFNλs; IL-28a,IL-28b,IL29和IFNλ4)的抗病毒活性的重要性。然而,许多病毒通过防止产生IFNS来抵消这些防御机制的策略。在这里,我们使用感染模型,临床病毒分离物和几种分子生物学技术,以证明I型和III IFNS诱导人类肠上皮细胞(IEC)中的抗病毒状态并衰减CoxSackeivirus Group B(CVB)复制。同时用病毒模拟物(Poly(I:C))诱导IEC的IEC,诱导I型和III IFNS的稳健表达,在CVB感染后没有观察到这种上调。钝化的IFN响应被诱导干扰素基因转录所涉及的蛋白质的丰度降低,包括含TIR-结构域的适配器诱导的干扰素-β(TRIF),线粒体抗病毒性信号蛋白(MAV)和全局蛋白翻译引发剂真核翻译开始因子4G(EIF4G)。在一起,该研究突出了位于感染初级部位的细胞中I和III IFNS两种I和III IFNS的有效的抗Coxsackieviral效果。此外,我们首次展示IECS中I和III IFNS的生产被CVBS阻止。这些研究结果表明,CVBS避免了宿主免疫应答,以便成功地感染肠道。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号